GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mtb PKS13 thioesterase domain in complex with inhibitor TAM5

Analyse Crystal structure of mtb PKS13 thioesterase domain in complex with inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5V41
Type
protein
Length
544 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Polyketide synthase PKS13 (termination polyketide synthase)
EC
2.7.7.-
UniProt
A0A0T9CRX1
Ligands
J24
Pockets
10 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 47% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APolyketide synthase PKS13 (termination polyketide synthase) (EC 2.7.7.-)protein27247% helix, 14% strandA0A0T9CRX1
BPolyketide synthase PKS13 (termination polyketide synthase) (EC 2.7.7.-)protein27246% helix, 15% strandA0A0T9CRX1

Ligands and binding sites

  • J24 · ethyl 5-hydroxy-4-(morpholin-4-ylmethyl)-2-phenyl-1-benzofuran-3-carboxylate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16420.710.7962empty
26810.710.7857J24
33400.560.7534empty
4710.440.8120empty
51450.430.7522empty

Interfaces

1 interface between chains.

  • A–B · 581 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 5V41 · Crystal Structure of Mtb Pks13 Thioesterase domain in complex with inhibitor TAM5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.